Prosecution Insights
Last updated: October 04, 2026

Dickinson Wright, PLLC

Technology area: Biotechnology & Pharmaceuticals

38 pending office actions • 11 clients • 33 examiners • 19 art units • 0 of 38 (0%) have an AI response strategy ready

Analysis

Dickinson Wright PLLC is a patent law firm with a volume of 26583 career applications. The firm specializes in Biotechnology & Pharmaceuticals. It maintains a resolved allowance rate pct of 86.08. This performance is achieved with an avg office actions per allowance of 3.23. The firm currently has 32 pending office actions.

The avg office actions per allowance of 3.23 suggests a prosecution style that involves several rounds of examiner interaction before an allowance is reached. This metric is consistent with the firm's performance across 26583 career applications. The resolved allowance rate pct of 86.08 shows the likelihood of success in the Biotechnology & Pharmaceuticals sector. With 32 pending office actions, the firm maintains a focused current docket relative to its historical volume. These data points provide a picture of the firm's historical success and current activity level. The firm's 26583 career applications define its experience in Biotechnology & Pharmaceuticals.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=26583 apps, methodology: how we score firms)

86.1%
Allowance Rate
n=26583
+0.51σ
Allowance Rate (norm)
n=26583
3.2
OAs to Allowance
n=17026
-0.16σ
OAs to Allow (norm)
n=17026
1027 days
Time to Allowance
n=17026
+7.9pp
Interview Lift
n=26583
24.6%
RCE Rate
n=26583
2.7%
Appeal Rate
n=26583

Rejection Performance (% of received rejections ultimately overcome)

70.8%
§101 Overcome
n=1683
78.3%
§102 Overcome
n=7322
78.6%
§103 Overcome
n=11804
81.0%
§112 Overcome
n=8171

Specialization & Scale

H04L, G06F, H04W
Top CPC Subclasses
11%
Top-3 CPC Share
n=26583
37
Practitioners
n=26583
718.5
Apps / Practitioner
n=26583

Portfolio Summary

38
Total Pending OAs
25
Non-Final OAs
13
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
2
Due this month
2
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 30 days (2)Due ≤ 60 days (2)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

24
Hard (63%)
11
Medium (29%)
3
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (8%)
§103 only5 (13%)
§102 only2 (5%)
§112 only3 (8%)
Double-patenting + other4 (11%)
Multi-statute (no §101)21 (55%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

22
Life Sciences
58% of docket
4
Information Tech
11% of docket
1
Communications
3% of docket
0
Semiconductors
0% of docket
6
Mechanical / Eng
16% of docket
5
Business / Other
13% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

380 h
Manual time on pending OAs
76 h
Time saved (low, 20%)
133 h
Time saved (mid, 35%)
3.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIM, YOUNG J 2 64.8% +18.1%
WILDER, CYNTHIA B 2 71.0% +26.6%
GOLDBERG, JEANINE ANNE 2 45.8% +40.8%
LAFAVE, ELIZABETH ROSE 2 62.5% +45.4%
FLINDERS, JEREMY C 2 63.5% +16.7%
CHEN, XUXING 1 86.1% +11.6%
PHAM, KHAI QUYNH TIEN 1 0.0% +0.0%
WU, STEPHANIE 1 81.2% +18.4%
SERRAGUARD, SEAN ERIN 1 69.1% +34.1%
MOORE, SUSANNA 1 68.1% +31.6%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18620529 MULTIPLEXED-RANK DUAL INLINE MEMORY MODULE (MRDIMM) VIRTUAL CONTROLLER MODE WU, STEPHANIE —

Hard Cases (24)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17996196 A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS PARISI, JESSICA DANIELLE 126d overdue
17751023 METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION LAFAVE, ELIZABETH ROSE 121d overdue
17421088 SYSTEMS AND METHODS FOR PHYSIOLOGY MONITORING GARMENT HADDAD, MOUSSA MAHER 74d overdue
18614235 DYNAMIC NATURAL LANGUAGE PROCESSING SYSTEM FOR IMPROVED CONTEXTUAL UNDERSTANDING AND INTERACTIVE RESPONSE SERRAGUARD, SEAN ERIN 71d overdue
18283754 CONDUCTIVE ELASTOMERIC FILAMENTS AND METHOD OF MAKING SAME BLAISE, BRADFORD CHRISTOPHER 66d overdue
17373653 cDNA SPIKE-IN CONTROL FOR SINGLE CELL ANALYSIS YU, TIAN NMN 51d overdue
18392707 SMART COLUMN ADDRESS STROBE (CAS) BURST CONTINUATION DARE, RYAN A 17d overdue
17421173 SYSTEMS AND METHODS FOR PHYSIOLOGY MONITORING KNEE BRACE FEDORKY, MEGAN TAYLOR 17d overdue

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17751023 METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION LAFAVE, ELIZABETH ROSE 121d overdue
18614235 DYNAMIC NATURAL LANGUAGE PROCESSING SYSTEM FOR IMPROVED CONTEXTUAL UNDERSTANDING AND INTERACTIVE RESPONSE SERRAGUARD, SEAN ERIN 71d overdue
17575094 SURFACE STRUCTURING WITH COLLOIDAL ASSEMBLY FLINDERS, JEREMY C 31d overdue
18251528 MULTIPLEX DETECTION OF BACTERIAL RESPIRATORY PATHOGENS GOLDBERG, JEANINE ANNE 28d overdue
17923506 COMPOSITIONS AND METHODS FOR MODIFYING POLYMERASE-NUCLEIC ACID COMPLEXES LAFAVE, ELIZABETH ROSE 15d
18251147 A METHOD FOR SINGLE-CELL NASCENT RNA LABELING AND SEQUENCING GOLDBERG, JEANINE ANNE 61d
19033094 Universal Declarative Framework for Automating Data Pipelines CHEN, XUXING —
18730043 PREPARING NUCLEIC ACID FOR FURTHER ANALYSIS OF THEIR SEQUENCE KIM, YOUNG J —

Client Portfolio (11 clients)

Top Art Units

Art UnitApps
16846
16825
16814
37922
37962
21761
16391
21331
26571
16241

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19033094 Universal Declarative Framework for Automating Data Pipelines Schemon Inc. CHEN, XUXING 2176 §103§112 Non-Final OA — Pending Jan 21, 2025
18730043 PREPARING NUCLEIC ACID FOR FURTHER ANALYSIS OF THEIR SEQUENCE BECTON, DICKINSON AND COMPANY KIM, YOUNG J §102 Non-Final OA — Pending Jul 18, 2024
18652519 DIGITAL COUNTING OF INDIVIDUAL MOLECULES BY STOCHASTIC ATTACHMENT OF DIVERSE LABELS BECTON, DICKINSON AND COMPANY PHAM, KHAI QUYNH TIEN 1639 §102§103 Non-Final OA — Pending May 01, 2024
18620529 MULTIPLEXED-RANK DUAL INLINE MEMORY MODULE (MRDIMM) VIRTUAL CONTROLLER MODE Advanced Micro Devices, Inc. WU, STEPHANIE 2133 §103 Non-Final OA — Pending Mar 28, 2024
18614235 DYNAMIC NATURAL LANGUAGE PROCESSING SYSTEM FOR IMPROVED CONTEXTUAL UNDERSTANDING AND INTERACTIVE RESPONSE Kamazooie Development Corporation SERRAGUARD, SEAN ERIN 2657 §102§103§112 Final Rejection 71d overdue Pending Mar 22, 2024
18692678 AN IMPROVED PROCESS FOR THE PREPARATION OF RUXOLITINIB PHOSPHATE Natco Pharma Limited MOORE, SUSANNA 1624 §103§112 Non-Final OA — Pending Mar 15, 2024
18688919 NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES BECTON, DICKINSON AND COMPANY WILDER, CYNTHIA B §112DP Non-Final OA — Pending Mar 04, 2024
18686936 NOVEL CRYSTALLINE POLYMORPH OF LURBINECTEDIN AND IMPROVED PROCESS FOR THE PREPARATION OF LURBINECTEDIN Natco Pharma Limited CORNET, JEAN P 1628 §112 Non-Final OA — Pending Feb 27, 2024
18686822 TEMPLATE SWITCH OLIGONUCLEOTIDE (TSO) FOR MRNA 5' ANALYSIS BECTON, DICKINSON AND COMPANY KOVACH, KARA NICOLE §101§102§112 Non-Final OA — Pending Feb 26, 2024
18686812 USE OF DECOY POLYNUCLEOTIDES IN SINGLE CELL MULTIOMICS BECTON, DICKINSON AND COMPANY KIM, YOUNG J 1681 §103§112 Non-Final OA — Pending Feb 26, 2024
18686824 MULTIPLEXED PROTEOMICS ANALYSIS USING OLIGONUCLEOTIDE-CONJUGATED ANTIBODIES BECTON, DICKINSON AND COMPANY NGUYEN, BAO THUY L §103§112 Non-Final OA — Pending Feb 26, 2024
18418143 ASSAY FOR DETECTING CLOSELY-RELATED SEROTYPES OF HUMAN PAPILLOMAVIRUS (HPV) BECTON, DICKINSON AND COMPANY WILDER, CYNTHIA B 1681 §112DP Non-Final OA — Pending Jan 19, 2024
18392707 SMART COLUMN ADDRESS STROBE (CAS) BURST CONTINUATION Advanced Micro Devices, Inc. DARE, RYAN A 2132 §102§103 Non-Final OA 17d overdue Pending Dec 21, 2023
18572149 SMART GARMENT FOR REMOTE DELIVERY OF THERAPY Mgi Holdco Ltd. LUAN, SCOTT 3792 §102§103 Final Rejection 72d Pending Dec 19, 2023
18540659 ISOTHERMAL AMPLIFICATION COMPONENTS AND PROCESSES Nat Diagnostics, Inc. MUMMERT, STEPHANIE KANE 1637 §102§103Other Non-Final OA — Pending Dec 14, 2023
18558035 METHODS FOR MAKING LIBRARIES FOR NUCLEIC ACID SEQUENCING BECTON, DICKINSON AND COMPANY TSUI, YUNG-SHENG M §102§103DP Final Rejection — Pending Oct 30, 2023
18374153 EFFICIENT BUS TURNAROUND FOR MEMORY CONTROLLER Advanced Micro Devices, Inc. LI, SIDNEY 2137 §102 Final Rejection — Pending Sep 28, 2023
18283754 CONDUCTIVE ELASTOMERIC FILAMENTS AND METHOD OF MAKING SAME Mgi Holding Ltd. BLAISE, BRADFORD CHRISTOPHER 3794 §102§103 Final Rejection 66d overdue Pending Sep 22, 2023
18548972 ISOTHERMAL AMPLIFICATION OF PATHOGENS BECTON, DICKINSON AND COMPANY HANEY, AMANDA MARIE 1682 §103§112 Non-Final OA — Pending Sep 05, 2023
18251536 RAPID IDENTIFICATION AND TYPING OF VIBRIO PARAHAEMOLYTICUS BECTON, DICKINSON AND COMPANY SWITZER, JULIET CAROLINE 1682 §103§112 Non-Final OA — Pending May 03, 2023
18251528 MULTIPLEX DETECTION OF BACTERIAL RESPIRATORY PATHOGENS BECTON, DICKINSON AND COMPANY GOLDBERG, JEANINE ANNE 1682 §103 Final Rejection 28d overdue Pending May 02, 2023
18251147 A METHOD FOR SINGLE-CELL NASCENT RNA LABELING AND SEQUENCING Singleron (Nanjing) Biotechnologies, Ltd. GOLDBERG, JEANINE ANNE 1682 §103§112 Final Rejection 61d Pending Apr 28, 2023
18194590 MASSIVELY PARALLEL SINGLE CELL ANALYSIS BECTON, DICKINSON AND COMPANY PRIEST, AARON A 1681 §103DP Final Rejection — Pending Mar 31, 2023
18058216 METHODS AND COMPOSITIONS FOR COMBINATORIAL BARCODING BECTON, DICKINSON AND COMPANY HAVLIN, ROBERT H 1626 §102§103Other Final Rejection 54d Pending Nov 22, 2022
17923506 COMPOSITIONS AND METHODS FOR MODIFYING POLYMERASE-NUCLEIC ACID COMPLEXES Pacific Biosciences of California, Inc. LAFAVE, ELIZABETH ROSE 1684 §102§103 Non-Final OA 15d Pending Nov 04, 2022
17996196 A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS Singleron (Nanjing) Biotechnologies, Ltd. PARISI, JESSICA DANIELLE 1684 §102§112 Final Rejection 126d overdue Pending Oct 13, 2022
17996195 METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT TARGET SEQUENCING IN SINGLE CELLS Singleron (Nanjing) Biotechnologies, Ltd. BOESEN, CHRISTIAN C 1684 §101§102 Non-Final OA — Pending Oct 13, 2022
17821449 MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES BECTON, DICKINSON AND COMPANY LU, FRANK WEI MIN 1683 §112 Non-Final OA — Pending Aug 22, 2022
17789735 CONDUCTIVE THERMOPLASTIC ELASTOMER ELECTRODES, AND METHOD OF MANUFACTURING SUCH ELECTRODES Mgi Holdco Ltd. LUKJAN, SEBASTIAN X 3792 §102§103 Final Rejection 33d Pending Jun 28, 2022
17751023 METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION Singleron Biotechnologies Inc. LAFAVE, ELIZABETH ROSE 1684 §102§103 Final Rejection 121d overdue Pending May 23, 2022
17684289 METHODS AND COMPOSITIONS FOR WHOLE TRANSCRIPTOME AMPLIFICATION BECTON, DICKINSON AND COMPANY FLINDERS, JEREMY C 1682 §103 Non-Final OA — Pending Mar 01, 2022
17575094 SURFACE STRUCTURING WITH COLLOIDAL ASSEMBLY Pacific Biosciences of California, Inc. FLINDERS, JEREMY C 1684 §103 Non-Final OA 31d overdue Pending Jan 13, 2022
17545845 MULTIPLEXED SINGLE CELL IMMUNOASSAY BECTON, DICKINSON AND COMPANY HANDY, DWAYNE K 1798 §102§103Other Non-Final OA — Pending Dec 08, 2021
17373653 cDNA SPIKE-IN CONTROL FOR SINGLE CELL ANALYSIS BECTON, DICKINSON AND COMPANY YU, TIAN NMN 1681 §103§112 Non-Final OA 51d overdue Pending Jul 12, 2021
17421173 SYSTEMS AND METHODS FOR PHYSIOLOGY MONITORING KNEE BRACE Mgi Holdco Ltd. FEDORKY, MEGAN TAYLOR 3796 §101§103 Non-Final OA 17d overdue Pending Jul 07, 2021
17421088 SYSTEMS AND METHODS FOR PHYSIOLOGY MONITORING GARMENT Mgi Holdco. Ltd. HADDAD, MOUSSA MAHER 3796 §103§112 Final Rejection 74d overdue Pending Jul 07, 2021
16959809 MULTI-FUNCTIONAL TUBULAR WORN GARMENT Mgi Holdco Ltd. ROBERTS, ANNA L 3791 §103 Non-Final OA — Pending Jul 02, 2020
16551620 SAMPLE MULTIPLEXING USING CARBOHYDRATE-BINDING AND MEMBRANE-PERMEABLE REAGENTS Cellular Research, Inc. BUNKER, AMY M 1684 §112 Non-Final OA 19d Pending Aug 26, 2019

Managing Dickinson Wright, PLLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month